FluidForm Bio successfully demonstrates advancements in engineered heart tissues with FRESH™ 3D bioprinting

FluidForm Bio, a leader in developing life-like human tissue to treat disease, shares recent advancements in building human cardiac tissues using FRESH™ 3D bioprinting.

AstraZeneca’s sBLA for LS-SCLC treatment gains FDA priority review

Imfinzi has a generally manageable safety profile, with no new safety signals detected during the trial. Credit: JHVEPhoto via Shutterstock. AstraZeneca has received priority review

August 16, 2024

Lilly drops body mass ranges from FDA label for weight loss drug

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

December 4, 2024

Ohio Voters Back Constitutional Right to Abortion

Ohio voters approved a constitutional amendment protecting access to abortion on Tuesday. The amendment also protects access to other types of reproductive healthcare, including contraception,

November 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.